Effect of teriflunomide on Epstein–Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study

•Saliva collection at home is a feasible method to detect EBV DNA and shedding.•Fewer samples from teriflunomide-treated patients with MS were positive for EBV DNA.•Fewer samples from teriflunomide-treated patients with MS were positive for EBV shedding. Given its potential antiviral activity, we in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis and related disorders 2022-12, Vol.68, p.104377-104377, Article 104377
Hauptverfasser:	Gold, Julian, Holden, David, Parratt, John, Yiannikas, Con, Ahmad, Raghib, Sedhom, Mamdouh, Giovannoni, Gavin
Format:	Artikel
Sprache:	eng
Schlagworte:	Cohort Studies Crotonates - pharmacology Crotonates - therapeutic use Epstein-Barr Virus Infections - complications Epstein-Barr Virus Infections - drug therapy Epstein–Barr virus Herpesvirus 4, Human Humans Infectious mononucleosis Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Pilot Projects Relapsing-remitting multiple sclerosis Teriflunomide
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!